coronavirus antibodies

The top 12 states using antibody therapies produced by Regeneron and Lilly, which research shows don’t work against omicron, include several Southern states with some of the lowest vaccination rates and California, which ranks among the top 20 for fully vaccinated residents.

Evusheld, which the FDA approved for emergency use, offers about six months of protection if administered before a patient is exposed to the virus, Gov. Ron DeSantis says.

Gov. Ron DeSantis said the state will receive 3,000 doses of sotrovimab, which received emergency use authorization in May, as the Biden administration begins rationing antibody treatments to Florida.

The drug combination from Regeneron Pharmaceuticals cut patient deaths from 30% to 24% among those who hadn’t already developed an immune response against COVID-19.

Regeneron says tests in more than 4,000 recently diagnosed patients found its two-antibody combo drug cut the risk of hospitalization or death by 70%.

Doctors say not enough people in South Florida seem to know about the treatment — an infusion of antibodies — that can prevent symptoms from worsening and stave off hospitalization or death.

A rheumatologist in Miami-Dade seeks volunteers for a double-blind, placebo-controlled pilot study to test a drug that would treat COVID-19 long-hauler syndrome.

The trial studied the efficacy of bamlanivimab in combination with the antiviral remdesivir on hospitalized COVID-19 patients. Researchers concluded the antibody treatment was "unlikely to help."

The president criticized the FDA this week for not giving emergency use approval to an experimental treatment for COVID-19. Scientists argue that the therapy still lacks sufficient evidence.

Iran has surpassed 20,000 confirmed deaths from the coronavirus.Wednesday's announcement comes as Iran struggles with the largest outbreak in the Middle…